IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction

被引:255
作者
Jabri, Bana [1 ,2 ,3 ]
Abadie, Valerie [4 ,5 ]
机构
[1] Univ Chicago, Dept Med, KCBD, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pathol, KCBD, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Pediat, KCBD, Chicago, IL 60637 USA
[4] Univ Montreal, Dept Microbiol Infect Dis & Immunol, Montreal, PQ H3T 1C5, Canada
[5] Ctr Hosp Univ CHU St Justine Res Ctr, Montreal, PQ H3T 1C5, Canada
基金
美国国家卫生研究院;
关键词
INTESTINAL EPITHELIAL-CELLS; NATURAL-KILLER-CELLS; DOUBLE-STRANDED-RNA; DENDRITIC CELLS; CELIAC-DISEASE; INTERLEUKIN; 15; NK CELLS; INTRAEPITHELIAL LYMPHOCYTES; TRANS-PRESENTATION; IMMUNE PRIVILEGE;
D O I
10.1038/nri3919
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
In this Opinion article, we discuss the function of tissues as a crucial checkpoint for the regulation of effector T cell responses, and the notion that interleukin-15 (IL-15) functions as a danger molecule that communicates to the immune system that the tissue is under attack and poises it to mediate tissue destruction. More specifically, we propose that expression of IL-15 in tissues promotes T helper 1 cell-mediated immunity and provides co-stimulatory signals to effector cytotoxic T cells to exert their effector functions and drive tissue destruction. Therefore, we think that IL-15 contributes to tissue protection by promoting the elimination of infected cells but that when its expression is chronically dysregulated, it can promote the development of complex T cell-mediated disorders associated with tissue destruction, such as coeliac disease and type 1 diabetes.
引用
收藏
页码:771 / 783
页数:13
相关论文
共 160 条
[1]
IL-15: a central regulator of celiac disease immunopathology [J].
Abadie, Valerie ;
Jabri, Bana .
IMMUNOLOGICAL REVIEWS, 2014, 260 (01) :221-234
[2]
Agostini C, 1996, J IMMUNOL, V157, P910
[3]
IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway [J].
Ahmed, Melika Ben ;
Hmida, Nadia Belhadj ;
Moes, Nicolette ;
Buyse, Sophie ;
Abdeladhim, Maha ;
Louzir, Hechmi ;
Cerf-Bensussan, Nadine .
JOURNAL OF IMMUNOLOGY, 2009, 182 (11) :6763-6770
[4]
CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions [J].
Allez, Matthieu ;
Tieng, Vannary ;
Nakazawa, Atsushi ;
Treton, Xavier ;
Pacault, Vincent ;
Dulphy, Nicolas ;
Caillat-Zucman, Sophie ;
Paul, Pascale ;
Gornet, Jean-Marc ;
Douay, Corinne ;
Ravet, Sophie ;
Tamouza, Ryad ;
Charron, Dominique ;
Lemann, Marc ;
Mayer, Lloyd ;
Toubert, Antoine .
GASTROENTEROLOGY, 2007, 132 (07) :2346-2358
[5]
Anguille S., 2013, HUM VACC IMMUNOTHER, V9, P1956
[6]
Autoimmune thyroid disorders [J].
Antonelli, Alessandro ;
Ferrari, Silvia Martina ;
Corrado, Alda ;
Di Domenicantonio, Andrea ;
Fallahi, Poupak .
AUTOIMMUNITY REVIEWS, 2015, 14 (02) :174-180
[7]
Serum interleukin-15 is elevated in systemic lupus erythematosus [J].
Aringer, M ;
Stummvoll, GH ;
Steiner, G ;
Köller, M ;
Steiner, CW ;
Höfler, E ;
Hiesberger, H ;
Smolen, JS ;
Graninger, WB .
RHEUMATOLOGY, 2001, 40 (08) :876-881
[8]
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[9]
Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum [J].
Bergamaschi, Cristina ;
Bear, Jenifer ;
Rosati, Margherita ;
Beach, Rachel Kelly ;
Alicea, Candido ;
Sowder, Raymond ;
Chertova, Elena ;
Rosenberg, Steven A. ;
Felber, Barbara K. ;
Pavlakis, George N. .
BLOOD, 2012, 120 (01) :E1-E8
[10]
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238